Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2264961000168114 | Psyllium husk and mebeverine | en | Synonym | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| 3521403012 | Product containing ispaghula husk and mebeverine (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3715392016 | Ispaghula husk- and mebeverine-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Psyllium husk and mebeverine | Is a | Mebeverine-containing product | true | Inferred relationship | Some | ||
| Psyllium husk and mebeverine | Is a | Ispaghula husk-containing product | true | Inferred relationship | Some | ||
| Psyllium husk and mebeverine | Has active ingredient | Psyllium husk | true | Inferred relationship | Some | 1 | |
| Psyllium husk and mebeverine | Has active ingredient | Mebeverine hydrochloride | false | Inferred relationship | Some | ||
| Psyllium husk and mebeverine | Has active ingredient | Antilipaemic agent | false | Inferred relationship | Some | ||
| Psyllium husk and mebeverine | Has active ingredient | Mebeverine | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ispaghula husk- and mebeverine-containing product in oral dose form | Is a | True | Psyllium husk and mebeverine | Inferred relationship | Some | |
| Ispaghula husk and mebeverine only product | Is a | True | Psyllium husk and mebeverine | Inferred relationship | Some | |
| Ispaghula husk 3.5 g and mebeverine hydrochloride 135 mg granules for oral suspension sachet | Is a | False | Psyllium husk and mebeverine | Inferred relationship | Some |
This concept is not in any reference sets
FHIR